These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 16713496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C, Pistrosch F, Herbrig K, Gross P.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [Abstract] [Full Text] [Related]

  • 3. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T.
    Cardiovasc Drug Rev; 2007 Jul; 25(1):1-13. PubMed ID: 17445084
    [Abstract] [Full Text] [Related]

  • 4. Vasopressin excess and hyponatremia.
    Pham PC, Pham PM, Pham PT.
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [Abstract] [Full Text] [Related]

  • 5. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G.
    Prog Brain Res; 2008 May; 170():473-512. PubMed ID: 18655903
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
    Cassagnol M, Shogbon AO, Saad M.
    J Pharm Pract; 2011 Aug; 24(4):391-9. PubMed ID: 21813818
    [Abstract] [Full Text] [Related]

  • 9. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR.
    Am J Cardiol; 2005 May 02; 95(9A):14B-23B. PubMed ID: 15847853
    [Abstract] [Full Text] [Related]

  • 10. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Patel GP, Balk RA.
    Clin Ther; 2007 Feb 02; 29(2):211-29. PubMed ID: 17472815
    [Abstract] [Full Text] [Related]

  • 11. Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan.
    Miyazaki T, Ohmoto K, Hirose T, Fujiki H.
    J Endocrinol; 2010 Jul 02; 206(1):105-11. PubMed ID: 20392812
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin-receptor antagonists.
    Hoorn EJ, Zietse R.
    Future Cardiol; 2010 Jul 02; 6(4):523-34. PubMed ID: 20608824
    [Abstract] [Full Text] [Related]

  • 13. [Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?].
    Hensen J, Buchfelder M, Gross P.
    Fortschr Med; 1997 Jun 20; 115(17):46-50. PubMed ID: 9312543
    [Abstract] [Full Text] [Related]

  • 14. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L, Schmidt PH, Gheorghiade M.
    Expert Rev Cardiovasc Ther; 2011 Dec 20; 9(12):1505-13. PubMed ID: 22103869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
    Reilly T, Schork MR.
    Ann Pharmacother; 2010 Apr 20; 44(4):680-7. PubMed ID: 20332337
    [Abstract] [Full Text] [Related]

  • 17. Treatment options for hyponatremia in heart failure.
    Goldsmith SR.
    Congest Heart Fail; 2010 Jul 20; 16 Suppl 1():S15-8. PubMed ID: 20653706
    [Abstract] [Full Text] [Related]

  • 18. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
    Gerbes AL, Gülberg V, Ginès P, Decaux G, Gross P, Gandjini H, Djian J, VPA Study Group.
    Gastroenterology; 2003 Apr 20; 124(4):933-9. PubMed ID: 12671890
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyponatremia: current treatment strategies and the role of vasopressin antagonists.
    Cawley MJ.
    Ann Pharmacother; 2007 May 20; 41(5):840-50. PubMed ID: 17405824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.